TreeWAS – Variant ID: rs982393

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z87.1 Personal history of diseases of the digestive system	0.000	0.985	0.015
G43.1 Migraine with aura [classical migraine]	0.010	0.990	0.000
K66.0 Peritoneal adhesions	0.000	0.990	0.010
K50.8 Other Crohn's disease	0.000	0.991	0.009
K50.9 Crohn's disease, unspecified	0.000	0.991	0.009
K50 Crohn's disease [regional enteritis]	0.000	0.991	0.009
N20.0 Calculus of kidney	0.000	0.992	0.008
K50.1 Crohn's disease of large intestine	0.000	0.992	0.008
N21.0 Calculus in bladder	0.000	0.993	0.007
Y45.0 Opioids and related analgesics	0.000	0.993	0.007
K50.0 Crohn's disease of small intestine	0.000	0.993	0.007
N21 Calculus of lower urinary tract	0.000	0.994	0.006
N20 Calculus of kidney and ureter	0.000	0.994	0.006
N20-N23 Urolithiasis	0.000	0.994	0.006
K56.6 Other and unspecified intestinal obstruction	0.000	0.994	0.006
K66 Other disorders of peritoneum	0.000	0.994	0.006
N20.9 Urinary calculus, unspecified	0.000	0.994	0.006
N23 Unspecified renal colic	0.000	0.994	0.006
J84.9 Interstitial pulmonary disease, unspecified	0.006	0.994	0.000
S89.9 Unspecified injury of lower leg	0.000	0.995	0.005
K66.1 Haemoperitoneum	0.000	0.995	0.005
N21.8 Other lower urinary tract calculus	0.000	0.995	0.005
N21.9 Calculus of lower urinary tract, unspecified	0.000	0.995	0.005
N40 Hyperplasia of prostate	0.000	0.995	0.005
J84 Other interstitial pulmonary diseases	0.005	0.995	0.000
K66.8 Other specified disorders of peritoneum	0.000	0.995	0.005
N21.1 Calculus in urethra	0.000	0.995	0.005
N22 Calculus of urinary tract in diseases classified elsewhere	0.000	0.995	0.004
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.000	0.995	0.005
K66.9 Disorder of peritoneum, unspecified	0.000	0.996	0.004
N20.2 Calculus of kidney with calculus of ureter	0.000	0.996	0.004
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.996	0.004
N03.9 Unspecified	0.004	0.996	0.000
I86.4 Gastric varices	0.000	0.996	0.004
Y51 Drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
J84.8 Other specified interstitial pulmonary diseases	0.004	0.996	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.000	0.996	0.004
N28.8 Other specified disorders of kidney and ureter	0.004	0.996	0.000
Y45.8 Other analgesics and antipyretics	0.000	0.996	0.004
J80 Adult respiratory distress syndrome	0.004	0.996	0.000
Y40.9 Systemic antibiotic, unspecified	0.000	0.996	0.004
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.996	0.004
J84.1 Other interstitial pulmonary diseases with fibrosis	0.004	0.996	0.000
J84.0 Alveolar and parietoalveolar conditions	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.000	0.996	0.004
N22.8 Calculus of urinary tract in other diseases classified elsewhere	0.000	0.996	0.003
N22.0 Calculus of urinary tract in schistosomiasis [bilharziasis]	0.000	0.996	0.003
I45.5 Other specified heart block	0.000	0.996	0.004
Y45.2 Propionic acid derivatives	0.000	0.996	0.003
Y53 Agents primarily affecting the gastro-intestinal system	0.000	0.996	0.003
J80-J84 Other respiratory diseases principally affecting the interstitium	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.000	0.997	0.003
Y45.5 4-Aminophenol derivatives	0.000	0.997	0.003
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
I45.6 Preexcitation syndrome	0.000	0.997	0.003
Y53.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
I45 Other conduction disorders	0.000	0.997	0.003
Y40 Systemic antibiotics	0.000	0.997	0.003
I34.1 Mitral (valve) prolapse	0.003	0.997	0.000
Y45.4 Antirheumatics	0.000	0.997	0.003
I45.1 Other and unspecified right bundle-branch block	0.000	0.997	0.003
I86.1 Scrotal varices	0.000	0.997	0.003
I45.3 Trifascicular block	0.000	0.997	0.003
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
Y53.4 Other laxatives	0.000	0.997	0.003
Y56.3 Emollients, demulcents and protectants	0.000	0.997	0.003
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.000	0.997	0.003
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.997	0.003
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
Y51.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
Y51.0 Anticholinesterase agents	0.000	0.997	0.003
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
D52.9 Folate deficiency anaemia, unspecified	0.003	0.997	0.000
G43 Migraine	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.000	0.997	0.003
Y56.8 Other topical agents	0.000	0.997	0.003
Y56.7 Dental drugs, topically applied	0.000	0.997	0.003
Y56.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
Y56.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
Y56.2 Local astringents and local detergents	0.000	0.997	0.003
Y56.1 Antipruritics	0.000	0.997	0.003
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.997	0.003
U88 Agent resistant to multiple antibiotics	0.003	0.997	0.000
I86 Varicose veins of other sites	0.000	0.997	0.003
Y40.3 Macrolides	0.000	0.997	0.003
Y49 Psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
I45.2 Bifascicular block	0.000	0.997	0.003
Y40.1 Cefalosporins and other -lactam antibiotics	0.000	0.997	0.003
Y54.8 Agents affecting uric acid metabolism	0.000	0.997	0.003
Y53.3 Saline and osmotic laxatives	0.000	0.997	0.003
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.000	0.997	0.003
S89 Other and unspecified injuries of lower leg	0.000	0.997	0.003
I45.9 Conduction disorder, unspecified	0.000	0.997	0.003
Y52 Agents primarily affecting the cardiovascular system	0.000	0.997	0.003
I45.0 Right fascicular block	0.000	0.997	0.003
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
Y53.7 Emetics	0.000	0.997	0.003
Y53.5 Digestants	0.000	0.997	0.003
Y53.0 Histamine H2-receptor antagonists	0.000	0.997	0.003
Y46 Antiepileptics and anti-Parkinsonism drugs	0.000	0.997	0.003
Y58 Bacterial vaccines	0.000	0.997	0.003
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.000	0.997	0.003
D03.3 Melanoma in situ of other and unspecified parts of face	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.000	0.997	0.003
Y54.7 Agents affecting calcification	0.000	0.997	0.003
Y40.2 Chloramphenicol group	0.000	0.997	0.003
Y46.4 Iminostilbenes	0.000	0.997	0.003
J82 Pulmonary eosinophilia, not elsewhere classified	0.003	0.997	0.000
Y40.7 Antifungal antibiotics, systemically used	0.000	0.997	0.003
Y54.3 Benzothiadiazine derivatives	0.000	0.997	0.003
Y49.2 Other and unspecified antidepressants	0.000	0.997	0.003
J81 Pulmonary oedema	0.003	0.997	0.000
G43.8 Other migraine	0.003	0.997	0.000
I45.4 Nonspecific intraventricular block	0.000	0.997	0.003
Y50 Central nervous system stimulants, not elsewhere classified	0.000	0.997	0.003
Y47 Sedatives, hypnotics and antianxiety drugs	0.000	0.997	0.002
Y40.5 Aminoglycosides	0.000	0.997	0.002
Y59 Other and unspecified vaccines and biological substances	0.000	0.997	0.002
U80.1 Methicillin resistant agent	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.000	0.997	0.002
Y54.6 Electrolytic, caloric and water-balance agents	0.000	0.997	0.002
Y54.2 Carbonic-anhydrase inhibitors	0.000	0.997	0.002
G43.3 Complicated migraine	0.002	0.997	0.000
G43.2 Status migrainosus	0.002	0.997	0.000
I86.3 Vulval varices	0.000	0.997	0.002
S89.8 Other specified injuries of lower leg	0.000	0.997	0.002
Y45.1 Salicylates	0.000	0.997	0.002
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.002
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.002
Y54.4 Loop [high-ceiling] diuretics	0.000	0.997	0.002
Y40.6 Rifamycins	0.000	0.997	0.002
Y40.4 Tetracyclines	0.000	0.997	0.002
Y54.0 Mineralocorticoids	0.000	0.997	0.002
Y40.0 Penicillins	0.000	0.997	0.002
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.002
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
G43.0 Migraine without aura [common migraine]	0.002	0.998	0.000
R20.8 Other and unspecified disturbances of skin sensation	0.000	0.998	0.002
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
I86.0 Sublingual varices	0.000	0.998	0.002
Y49.9 Psychotropic drug, unspecified	0.000	0.998	0.002
Y49.7 Psychostimulants with abuse potential	0.000	0.998	0.002
Y49.6 Psychodysleptics [hallucinogens]	0.000	0.998	0.002
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
I45.8 Other specified conduction disorders	0.000	0.998	0.002
Y49.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
S89.7 Multiple injuries of lower leg	0.000	0.998	0.002
S89.1 Other specified injuries of lower leg	0.000	0.998	0.002
S89.0 Multiple injuries of lower leg	0.000	0.998	0.002
Y49.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
Y58.0 BCG vaccine	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.000	0.998	0.002
Y46.3 Deoxybarbiturates	0.000	0.998	0.002
Y46.1 Oxazolidinediones	0.000	0.998	0.002
Y46.0 Succinimides	0.000	0.998	0.002
Y58.9 Other and unspecified bacterial vaccines	0.000	0.998	0.002
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.000	0.998	0.002
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.000	0.998	0.002
Y58.5 Diphtheria vaccine	0.000	0.998	0.002
Y58.4 Tetanus vaccine	0.000	0.998	0.002
Y58.3 Plague vaccine	0.000	0.998	0.002
Y58.2 Cholera vaccine	0.000	0.998	0.002
Y58.1 Typhoid and paratyphoid vaccine	0.000	0.998	0.002
Y40.8 Other systemic antibiotics	0.000	0.998	0.002
Y48 Anaesthetics and therapeutic gases	0.000	0.998	0.002
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
N03 Chronic nephritic syndrome	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.000	0.998	0.002
I86.8 Varicose veins of other specified sites	0.000	0.998	0.002
S80.8 Other superficial injuries of lower leg	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.000	0.998	0.002
Y46.5 Valproic acid	0.000	0.998	0.002
Y41 Other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
Y52.1 Calcium-channel blockers	0.000	0.998	0.002
U80 Agent resistant to penicillin and related antibiotics	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.000	0.998	0.002
Y50.9 Central nervous system stimulant, unspecified	0.000	0.998	0.002
Y50.8 Other central nervous system stimulants	0.000	0.998	0.002
Y50.1 Opioid receptor antagonists	0.000	0.998	0.002
Y50.0 Analeptics	0.000	0.998	0.002
I86.2 Pelvic varices	0.000	0.998	0.002
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.000	0.998	0.002
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.000	0.998	0.002
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.000	0.998	0.002
Y47.4 Bromine compounds	0.000	0.998	0.002
Y47.3 Paraldehyde	0.000	0.998	0.002
Y47.2 Chloral derivatives	0.000	0.998	0.002
Y47.0 Barbiturates, not elsewhere classified	0.000	0.998	0.002
Y54.5 Other diuretics	0.000	0.998	0.002
S92.30 Fracture of metatarsal bone (closed)	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
Y59.9 Vaccine or biological substance, unspecified	0.000	0.998	0.002
Y59.8 Other specified vaccines and biological substances	0.000	0.998	0.002
Y59.2 Protozoal vaccines	0.000	0.998	0.002
Y59.1 Rickettsial vaccines	0.000	0.998	0.002
Y49.5 Other antipsychotics and neuroleptics	0.000	0.998	0.002
Y52.7 Peripheral vasodilators	0.000	0.998	0.002
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.000	0.998	0.002
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
Y46.6 Other and unspecified antiepileptics	0.000	0.998	0.002
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
Y55.5 Anticommon cold drugs	0.000	0.998	0.002
Y55.3 Antitussives	0.000	0.998	0.002
Y55.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
Y59.3 Immunoglobulin	0.000	0.998	0.002
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
Y57 Other and unspecified drugs and medicaments	0.000	0.998	0.002
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.000	0.998	0.002
Y55.0 Oxytocic drugs	0.000	0.998	0.002
Y59.0 Viral vaccines	0.000	0.998	0.002
Z98.0 Intestinal bypass and anastomosis status	0.000	0.998	0.002
Y55.4 Expectorants	0.000	0.998	0.002
Z98.1 Arthrodesis status	0.000	0.998	0.002
I42.0 Dilated cardiomyopathy	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
N03.8 Other	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.000	0.998	0.002
Y48.5 Therapeutic gases	0.000	0.998	0.002
Y48.1 Parenteral anaesthetics	0.000	0.998	0.002
Y48.0 Inhaled anaesthetics	0.000	0.998	0.002
M13.97 Arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
N03.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.000	0.998	0.002
Y44.5 Thrombolytic drugs	0.000	0.998	0.002
N03.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N03.6 Dense deposit disease	0.002	0.998	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N03.0 Minor glomerular abnormality	0.002	0.998	0.000
U80.0 Penicillin resistant agent	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
Y41.4 Anthelminthics	0.000	0.998	0.002
Y41.3 Other antiprotozoal drugs	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.998	0.002
Y44.7 Plasma substitutes	0.000	0.998	0.002
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.998	0.002
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.000	0.998	0.002
U80.8 Agent resistant to other penicillin-related antibiotic	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
M23.30 Other meniscus derangements (Multiple sites)	0.002	0.998	0.000
B37.8 Candidiasis of other sites	0.002	0.998	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.998	0.002
Y41.0 Sulphonamides	0.000	0.998	0.002
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.000	0.998	0.002
Y43 Primarily systemic agents	0.000	0.998	0.002
N03.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.001
M48.06 Spinal stenosis (Lumbar region)	0.000	0.998	0.002
K31.5 Obstruction of duodenum	0.000	0.998	0.002
Y48.4 Anaesthetic, unspecified	0.000	0.998	0.001
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.000	0.998	0.001
Y48.2 Other and unspecified general anaesthetics	0.000	0.998	0.001
Y57.7 Vitamins, not elsewhere classified	0.000	0.998	0.002
Y57.4 Pharmaceutical excipients	0.000	0.998	0.002
Y57.3 Alcohol deterrents	0.000	0.998	0.002
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
Y57.1 Lipotropic drugs	0.000	0.998	0.002
Y57.0 Appetite depressants [anorectics]	0.000	0.998	0.002
U84 Resistance to other antimicrobial drugs	0.002	0.998	0.000
U83 Resistance to other antibiotics	0.002	0.998	0.000
U82 Resistance to betalactam antibiotics	0.002	0.998	0.000
U85 Resistance to antineoplastic drugs	0.002	0.998	0.000
K65-K67 Diseases of peritoneum	0.000	0.998	0.002
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.002	0.998	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.000	0.998	0.002
Y43.4 Immunosuppressive agents	0.000	0.998	0.002
Y57.8 Other drugs and medicaments	0.000	0.998	0.002
R80 Isolated proteinuria	0.002	0.998	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.000	0.998	0.002
Y57.6 Other diagnostic agents	0.000	0.998	0.001
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.001
Y57.5 X-ray contrast media	0.000	0.998	0.001
F00.9 Dementia in Alzheimer's disease, unspecified	0.000	0.998	0.002
U81 Agent resistant to vancomycin and related antibiotics	0.002	0.998	0.000
U89 Agent resistant to other and unspecified antibiotics	0.001	0.998	0.000
F41.2 Mixed anxiety and depressive disorder	0.000	0.998	0.002
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.002	0.998	0.000
S70.9 Superficial injury of hip and thigh, unspecified	0.000	0.998	0.002
B07 Viral warts	0.002	0.998	0.000
Z98 Other postsurgical states	0.000	0.998	0.002
B00.1 Herpesviral vesicular dermatitis	0.002	0.998	0.000
R00.8 Other and unspecified abnormalities of heart beat	0.000	0.998	0.002
Y43.9 Primarily systemic agent, unspecified	0.000	0.998	0.001
Y43.8 Other primarily systemic agents, not elsewhere classified	0.000	0.998	0.001
Y43.6 Enzymes, not elsewhere classified	0.000	0.998	0.001
Y43.5 Acidifying and alkalising agents	0.000	0.998	0.001
Y43.2 Antineoplastic natural products	0.000	0.998	0.001
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.001	0.998	0.000
R00.2 Palpitations	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.001
N05.9 Unspecified	0.001	0.998	0.000
U82.9 Resistance to betalactam antibiotics, unspecified	0.001	0.998	0.000
U82.8 Resistance to other betalactam antibiotics	0.001	0.998	0.000
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.001	0.998	0.000
U82.1 Resistance to methicillin	0.001	0.998	0.000
U82.0 Resistance to penicillin	0.001	0.998	0.000
U83.9 Resistance to unspecified antibiotic	0.001	0.998	0.000
U83.8 Resistance to other single specified antibiotic	0.001	0.998	0.000
U83.7 Resistance to multiple antibiotics	0.001	0.998	0.000
U83.2 Resistance to quinolones	0.001	0.998	0.000
U83.1 Resistance to other vancomycin related antibiotics	0.001	0.998	0.000
U83.0 Resistance to vancomycin	0.001	0.998	0.000
U84.9 Resistance to unspecified antimicrobial drugs	0.001	0.998	0.000
U84.8 Resistance to other specified antimicrobial drug	0.001	0.998	0.000
U84.7 Resistance to multiple antimicrobial drugs	0.001	0.998	0.000
U84.3 Resistance to tuberculostatic drug(s)	0.001	0.998	0.000
U84.2 Resistance to antiviral drug(s)	0.001	0.998	0.000
U84.1 Resistance to antifungal drug(s)	0.001	0.998	0.000
U84.0 Resistance to antiparasitic drug(s)	0.001	0.998	0.000
K67 Disorders of peritoneum in infectious diseases classified elsewhere	0.000	0.998	0.001
U50 Level of care administered to neonates	0.001	0.998	0.000
U07 Emergency use of U07	0.001	0.998	0.000
U06 Emergency use of U06	0.001	0.998	0.000
U04 Severe acute respiratory syndrome [SARS]	0.001	0.998	0.000
U52 First in a series of a regular day/night admissions	0.001	0.998	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.001	0.998	0.000
S81.0 Open wound of knee	0.001	0.998	0.000
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)	0.001	0.999	0.000
S92.3 Fracture of metatarsal bone	0.001	0.999	0.000
U89.9 Agent resistant to unspecified antibiotic	0.001	0.999	0.000
D52 Folate deficiency anaemia	0.001	0.999	0.000
M51.8 Other specified intervertebral disk disorders	0.001	0.999	0.000
M84.1 Nonunion of fracture [pseudarthrosis]	0.001	0.999	0.000
U81.0 Vancomycin resistant agent	0.001	0.999	0.000
Q21.1 Atrial septal defect	0.001	0.999	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.999	0.001
Z98.8 Other specified postsurgical states	0.000	0.999	0.001
Y43.0 Antiallergic and antiemetic drugs	0.000	0.999	0.001
Chapter XXII Codes for special purposes	0.001	0.999	0.000
S70.1 Contusion of thigh	0.000	0.999	0.001
Y43.1 Antineoplastic antimetabolites	0.000	0.999	0.001
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.999	0.001
M87.20 Osteonecrosis due to previous trauma (Multiple sites)	0.000	0.999	0.001
R90.0 Intracranial space-occupying lesion	0.001	0.999	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.999	0.001
F05.9 Delirium, unspecified	0.001	0.999	0.000
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.999	0.001
K67.8 Other disorders of peritoneum in infectious diseases classified elsewhere	0.000	0.999	0.001
K67.3 Tuberculous peritonitis	0.000	0.999	0.001
K67.2 Syphilitic peritonitis	0.000	0.999	0.001
K67.1 Gonococcal peritonitis	0.000	0.999	0.001
K67.0 Chlamydial peritonitis	0.000	0.999	0.001
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.001	0.999	0.000
U06.9 Emergency use of U06.9	0.001	0.999	0.000
U06.8 Emergency use of U06.8	0.001	0.999	0.000
U06.7 Emergency use of U06.7	0.001	0.999	0.000
U06.6 Emergency use of U06.6	0.001	0.999	0.000
U06.5 Emergency use of U06.5	0.001	0.999	0.000
U06.4 Emergency use of U06.4	0.001	0.999	0.000
U06.3 Emergency use of U06.3	0.001	0.999	0.000
U06.2 Emergency use of U06.2	0.001	0.999	0.000
U06.1 Emergency use of U06.1	0.001	0.999	0.000
U06.0 Emergency use of U06.0	0.001	0.999	0.000
U07.9 Emergency use of U07.9	0.001	0.999	0.000
U07.8 Emergency use of U07.8	0.001	0.999	0.000
U07.7 Emergency use of U07.7	0.001	0.999	0.000
U07.6 Emergency use of U07.6	0.001	0.999	0.000
U07.5 Emergency use of U07.5	0.001	0.999	0.000
U07.4 Emergency use of U07.4	0.001	0.999	0.000
U07.3 Emergency use of U07.3	0.001	0.999	0.000
U07.2 Emergency use of U07.2	0.001	0.999	0.000
U07.1 Emergency use of U07.1	0.001	0.999	0.000
U07.0 Emergency use of U07.0	0.001	0.999	0.000
U50.9 Inquest Adjourned Death	0.001	0.999	0.000
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.001	0.999	0.000
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.001	0.999	0.000
U50.1 Level of care administered to neonates (Special Care)	0.001	0.999	0.000
U50.0 Level of care administered to neonates (Normal Care)	0.001	0.999	0.000
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.001	0.999	0.000
G30.9 Alzheimer's disease, unspecified	0.000	0.999	0.001
I42.6 Alcoholic cardiomyopathy	0.001	0.999	0.000
S92.31 Fracture of metatarsal bone (open)	0.001	0.999	0.000
D12.0 Caecum	0.000	0.999	0.001
D52.8 Other folate deficiency anaemias	0.001	0.999	0.000
D52.1 Drug-induced folate deficiency anaemia	0.001	0.999	0.000
D52.0 Dietary folate deficiency anaemia	0.001	0.999	0.000
G30.0 Alzheimer's disease with early onset	0.000	0.999	0.001
T39.0 Salicylates	0.000	0.999	0.001
U51 Admission status on psychiatric patients	0.001	0.999	0.000
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)	0.001	0.999	0.000
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.001	0.999	0.000
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)	0.001	0.999	0.000
S70.0 Contusion of hip	0.000	0.999	0.001
W08.0 Home	0.000	0.999	0.001
Z48.8 Other specified surgical follow-up care	0.000	0.999	0.001
Z98.2 Presence of cerebrospinal fluid drainage device	0.000	0.999	0.001
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.999	0.001
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.001	0.999	0.000
B02.9 Zoster without complication	0.001	0.999	0.000
B37.7 Candidal septicaemia	0.001	0.999	0.000
G60.8 Other hereditary and idiopathic neuropathies	0.000	0.999	0.001
O90.8 Other complications of the puerperium, not elsewhere classified	0.000	0.999	0.001
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.999	0.001
Y44.2 Anticoagulants	0.000	0.999	0.001
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.001	0.999	0.000
S70 Superficial injury of hip and thigh	0.000	0.999	0.001
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.999	0.001
D36.1 Peripheral nerves and autonomic nervous system	0.000	0.999	0.001
N05.1 Focal and segmental glomerular lesions	0.001	0.999	0.000
O23.5 Infections of the genital tract in pregnancy	0.001	0.999	0.000
S70.7 Multiple superficial injuries of hip and thigh	0.000	0.999	0.001
B00 Herpesviral [herpes simplex] infections	0.001	0.999	0.000
F00 Dementia in Alzheimer's disease	0.000	0.999	0.001
M80.9 Unspecified osteoporosis with pathological fracture	0.001	0.999	0.000
Y42.4 Oral contraceptives	0.000	0.999	0.001
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.000	0.999	0.001
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.001	0.999	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.999	0.001
T40.4 Other synthetic narcotics	0.000	0.999	0.001
Y42.9 Other and unspecified hormone antagonists	0.000	0.999	0.001
Y42.2 Antithyroid drugs	0.000	0.999	0.001
Y57.9 Drug or medicament, unspecified	0.000	0.999	0.001
Z97.4 Presence of external hearing-aid	0.001	0.999	0.000
B37 Candidiasis	0.001	0.999	0.000
R90 Abnormal findings on diagnostic imaging of central nervous system	0.001	0.999	0.000
M49.54 Collapsed vertebra in diseases classified elsewhere (Thoracic region)	0.001	0.999	0.000
M84.18 Nonunion of fracture [pseudarthrosis] (Other)	0.001	0.999	0.000
N05.8 Other	0.001	0.999	0.000
R06.2 Wheezing	0.000	0.999	0.001
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.999	0.001
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.999	0.001
N05 Unspecified nephritic syndrome	0.001	0.999	0.000
K50-K52 Noninfective enteritis and colitis	0.000	0.999	0.001
M23.35 Other meniscus derangements (Posterior horn of lateral meniscus)	0.001	0.999	0.000
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)	0.001	0.999	0.000
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)	0.001	0.999	0.000
B00.5 Herpesviral ocular disease	0.001	0.999	0.000
B37.2 Candidiasis of skin and nail	0.001	0.999	0.000
K85.9 Acute pancreatitis, unspecified	0.000	0.999	0.001
O12.0 Gestational oedema	0.000	0.999	0.001
T38.9 Other and unspecified hormone antagonists	0.000	0.999	0.001
T38.7 Androgens and anabolic congeners	0.000	0.999	0.001
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.999	0.001
T38.5 Other oestrogens and progestogens	0.000	0.999	0.001
T38.4 Oral contraceptives	0.000	0.999	0.001
T38.2 Antithyroid drugs	0.000	0.999	0.001
T38.0 Glucocorticoids and synthetic analogues	0.000	0.999	0.001
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.999	0.001
I34 Nonrheumatic mitral valve disorders	0.001	0.999	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.001	0.999	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.000	0.999	0.001
T40.5 Cocaine	0.000	0.999	0.001
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.999	0.001
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.999	0.001
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.999	0.001
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.999	0.001
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.999	0.001
T44.0 Anticholinesterase agents	0.000	0.999	0.001
U89.8 Agent resistant to other single specified antibiotic	0.001	0.999	0.000
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.999	0.001
B00.7 Disseminated herpesviral disease	0.001	0.999	0.000
B00.3 Herpesviral meningitis	0.001	0.999	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.999	0.001
X41.9 Unspecified place	0.001	0.999	0.000
Y42.1 Thyroid hormones and substitutes	0.000	0.999	0.001
Z12.0 Special screening examination for neoplasm of stomach	0.000	0.999	0.001
R81 Glycosuria	0.001	0.999	0.000
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)	0.001	0.999	0.000
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)	0.001	0.999	0.000
M80.94 Unspecified osteoporosis with pathological fracture (Hand)	0.001	0.999	0.000
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)	0.001	0.999	0.000
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)	0.001	0.999	0.000
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)	0.001	0.999	0.000
B00.0 Eczema herpeticum	0.001	0.999	0.000
B37.6 Candidal endocarditis	0.001	0.999	0.000
B37.5 Candidal meningitis	0.001	0.999	0.000
I42.1 Obstructive hypertrophic cardiomyopathy	0.001	0.999	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.001	0.999	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.001	0.999	0.000
M19.03 Primary arthrosis of other joints (Forearm)	0.000	0.999	0.001
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.001	0.999	0.000
S12.10 Fracture of second cervical vertebra (closed)	0.001	0.999	0.000
E10.6 With other specified complications	0.000	0.999	0.001
G63.2 Diabetic polyneuropathy	0.000	0.999	0.001
I42.8 Other cardiomyopathies	0.001	0.999	0.000
M20.2 Hallux rigidus	0.001	0.999	0.000
N05.6 Dense deposit disease	0.001	0.999	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.001	0.999	0.000
N05.0 Minor glomerular abnormality	0.001	0.999	0.000
R82.4 Acetonuria	0.001	0.999	0.000
B00.9 Herpesviral infection, unspecified	0.001	0.999	0.000
B35.3 Tinea pedis	0.001	0.999	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.000	0.999	0.001
S70.8 Other superficial injuries of hip and thigh	0.000	0.999	0.001
U51.0 Not Previously admitted to a psyciatric hospital	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations